Pfizer vet to lead 1 new phase 3-ready biotech as CEO
A long-time Pfizer vet has been appointed CEO of a newly formed biotech company. The firm is already poised to enter phase 3 trials for its lead candidate.
A long-time Pfizer vet has been appointed CEO of a newly formed biotech company. The firm is already poised to enter phase 3 trials for its lead candidate.
As pressure mounts on former president Jair Bolsonaro, his political future hangs in the balance. Two of five judges have found him guilty in a key electoral trial.
NATO scrambled jets as a precaution after Russia launched a massive missile and drone attack on Ukraine, with targets located just miles from the polish border.
Laura Ingraham details how the policies of President Biden and the Democrats are actively putting our country at risk. Explore the key areas of concern today.
Widespread Gen Z demonstrations turn violent as protestors storm prisons and set fire to multiple government buildings and the private homes of public officials.
Former ICE Director Tom Homan unleashes on a ‘Morning Joe’ host for accusing agents of ‘disappearing people,’ calling the remarks dangerous and irresponsible.
Anglo American announces a historic merger deal with Teck Resources, creating a mining giant. Learn about the second-largest deal ever in the mining industry.
Following a major immigration raid in Georgia, top business chiefs are now urging the Trump administration to reconsider its harsh crackdown on immigrant labor.
The Missouri House has approved a new congressional redistricting plan. See how this move is part of a larger Republican strategy to maintain their House majority.
An alleged serial killer has been charged in the deaths of 2 victims and an attack on a third person, reportedly using a popular dating app to find his targets.